Verition Fund Management LLC Trims Stock Position in ICU Medical, Inc. (NASDAQ:ICUI)

Verition Fund Management LLC lessened its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 37.0% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,698 shares of the medical instruments supplier’s stock after selling 997 shares during the period. Verition Fund Management LLC’s holdings in ICU Medical were worth $309,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. SG Americas Securities LLC raised its position in ICU Medical by 441.7% in the second quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier’s stock worth $691,000 after acquiring an additional 4,744 shares during the period. LMR Partners LLP bought a new position in ICU Medical in the 3rd quarter worth $3,884,000. Savant Capital LLC purchased a new position in ICU Medical during the second quarter valued at $431,000. First Eagle Investment Management LLC bought a new stake in ICU Medical during the second quarter valued at about $3,479,000. Finally, MetLife Investment Management LLC increased its position in ICU Medical by 129.1% in the third quarter. MetLife Investment Management LLC now owns 12,389 shares of the medical instruments supplier’s stock worth $2,258,000 after buying an additional 6,981 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on ICUI shares. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective on the stock in a research report on Wednesday. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Raymond James increased their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. KeyCorp lifted their target price on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Finally, StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $177.25.

Insider Buying and Selling at ICU Medical

In other news, COO Christian B. Voigtlander sold 1,962 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $169.08, for a total transaction of $331,734.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $162.91, for a total transaction of $1,954,920.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at $17,039,245.63. This represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 40,364 shares of company stock worth $6,869,878. Insiders own 6.70% of the company’s stock.

ICU Medical Trading Down 2.4 %

ICU Medical stock opened at $161.64 on Friday. ICU Medical, Inc. has a 1 year low of $86.80 and a 1 year high of $196.26. The firm’s 50 day moving average price is $171.12 and its 200-day moving average price is $150.98. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The stock has a market cap of $3.96 billion, a P/E ratio of -35.37 and a beta of 0.62.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.